These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

471 related articles for article (PubMed ID: 22187129)

  • 1. Value of the metastatic lymph node ratio for predicting the prognosis of non-small-cell lung cancer patients.
    Wang CL; Li Y; Yue DS; Zhang LM; Zhang ZF; Sun BS
    World J Surg; 2012 Feb; 36(2):455-62. PubMed ID: 22187129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Value of metastatic lymph node ratio in predicting the prognosis of non-small cell lung cancer patients].
    Li Y; Sun BS; Zhang ZF; Zhang LM; Wang CL
    Zhonghua Yi Xue Za Zhi; 2011 Jun; 91(24):1682-6. PubMed ID: 21914316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic value of ratio-based lymph node staging in resected non-small-cell lung cancer.
    Qiu C; Dong W; Su B; Liu Q; Du J
    J Thorac Oncol; 2013 Apr; 8(4):429-35. PubMed ID: 23486264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymph node ratio as a prognostic factor in patients with pathological N2 non-small cell lung cancer.
    Tamura M; Matsumoto I; Saito D; Yoshida S; Takata M; Takemura H
    World J Surg Oncol; 2016 Nov; 14(1):295. PubMed ID: 27884195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of metastatic N1 lymph node ratio and angiolymphatic invasion in patients with pathologic stage IIA non-small cell lung cancer.
    Wu CF; Wu CY; Fu JY; Wang CW; Liu YH; Hsieh MJ; Wu YC
    Medicine (Baltimore); 2014 Oct; 93(20):e102. PubMed ID: 25365403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymph node ratio predicts recurrence and survival after R0 resection for non-small cell lung cancer.
    Taylor MD; LaPar DJ; Thomas CJ; Persinger M; Stelow EB; Kozower BD; Lau CL; Jones DR
    Ann Thorac Surg; 2013 Oct; 96(4):1163-1170. PubMed ID: 23998409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymph node ratio may predict the benefit of postoperative radiotherapy in non-small-cell lung cancer.
    Urban D; Bar J; Solomon B; Ball D
    J Thorac Oncol; 2013 Jul; 8(7):940-6. PubMed ID: 23695418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of the lymph node ratio as a prognostic factor in patients with N1 nonsmall cell lung cancer.
    Jonnalagadda S; Arcinega J; Smith C; Wisnivesky JP
    Cancer; 2011 Oct; 117(20):4724-31. PubMed ID: 21452193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The lymph node ratio as an independent prognostic factor for non-metastatic node-positive breast cancer recurrence and mortality.
    Solak M; Turkoz FP; Keskin O; Aksoy S; Babacan T; Sarici F; Kertmen N; Sever AR; Altundag K
    J BUON; 2015; 20(3):737-45. PubMed ID: 26214625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical study on the effects of neoadjuvant chemotherapy on lymph node ratio, prognosis, and survival analysis of stage ⅢA-N2 non-small cell lung cancer].
    Wei YL; Cui YH; Dong YH; Shi WJ
    Zhonghua Yi Xue Za Zhi; 2021 Jan; 101(4):259-264. PubMed ID: 33486934
    [No Abstract]   [Full Text] [Related]  

  • 11. Comprehensive analysis of metastatic N1 lymph nodes in completely resected non-small-cell lung cancer.
    Park S; Cho S; Yum SW; Kim K; Jheon S
    Interact Cardiovasc Thorac Surg; 2015 Nov; 21(5):624-9. PubMed ID: 26242319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mediastinal downstaging after induction treatment is not a significant prognostic factor to select patients who would benefit from surgery: the clinical value of the lymph node ratio.
    Renaud S; Falcoz PE; Olland A; Reeb J; Santelmo N; Massard G
    Interact Cardiovasc Thorac Surg; 2015 Feb; 20(2):222-7. PubMed ID: 25413781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors associated with recurrence of surgically resected node-positive non-small cell lung cancer.
    Ohtaki Y; Shimizu K; Kaira K; Nagashima T; Obayashi K; Nakazawa S; Kakegawa S; Igai H; Kamiyoshihara M; Nishiyama M; Takeyoshi I
    Surg Today; 2016 Oct; 46(10):1196-208. PubMed ID: 26782692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Negative Lymph Node Count Predicts Survival of Resected Non-small Cell Lung Cancer.
    Zhou X; Wu C; Cheng Q
    Lung; 2020 Oct; 198(5):839-846. PubMed ID: 32683563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of number of metastatic lymph nodes and metastatic lymph node ratio on the prognosis in patients with adenocarcinoma of the esophagogastric junction after curative resection].
    Zhang H; Chen C; Yue J; Ma M; Ma Z; Yu Z
    Zhonghua Zhong Liu Za Zhi; 2014 Feb; 36(2):141-6. PubMed ID: 24796465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The lymph node ratio predicts cancer-specific survival of node-positive non-small cell lung cancer patients: a population-based SEER analysis.
    Kai L; Zhoumiao C; Shaohua X; Zhao C; Zhijun L; Zhengfu H; Xiujun C
    J Cardiothorac Surg; 2021 Jan; 16(1):13. PubMed ID: 33468199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Significance of the Number of Metastatic pN2 Lymph Nodes in Stage IIIA-N2 Non-Small-Cell Lung Cancer After Curative Resection.
    Yoo C; Yoon S; Lee DH; Park SI; Kim DK; Kim YH; Kim HR; Choi SH; Kim WS; Choi CM; Jang SJ; Song SY; Kim SS; Choi EK; Lee JC; Suh C; Lee JS; Kim SW
    Clin Lung Cancer; 2015 Nov; 16(6):e203-12. PubMed ID: 25997733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Log odds of positive lymph nodes may predict survival benefit in patients with node-positive non-small cell lung cancer.
    Deng W; Xu T; Wang Y; Xu Y; Yang P; Gomez D; Liao Z
    Lung Cancer; 2018 Aug; 122():60-66. PubMed ID: 30032846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic role of station 3A mediastinal nodes for non-small-cell lung cancers.
    Zheng H; Gao W; Fei K; Xie HK; Jiang GN; Ding JA; Li C; Chen C; Zhang L
    Interact Cardiovasc Thorac Surg; 2013 Sep; 17(3):447-54. PubMed ID: 23788199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathological characteristics and lymph node metastasis pathway of non-small-cell lung cancer located in the left lingular division.
    Shien K; Toyooka S; Soh J; Okami J; Higashiyama M; Kadota Y; Maeda H; Hayama M; Chida M; Funaki S; Okumura M; Miyoshi S
    Interact Cardiovasc Thorac Surg; 2015 Jun; 20(6):791-6. PubMed ID: 25805399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.